A Buchwald–Hartwig Protocol to Enable Rapid Linker Exploration of Cereblon E3-Ligase PROTACs**

A palladium-catalysed Buchwald–Hartwig amination for lenalidomide-derived aryl bromides was optimised using high throughput experimentation (HTE). The substrate scope of the optimised conditions was evaluated for a range of alkyl- and aryl- amines and functionalised aryl bromides. The methodology allows access to new cereblon-based bifunctional proteolysis targeting chimeras with a reduced step count and improved yields.     

Group 6 Oxyfluoro-Anion Salts of [XeF5]+ and [Xe2F11]+: Syntheses and Structures of [XeF5][M2O2F9] (M=Mo,W), [Xe2F11][M′OF5] (M′=Cr,Mo, W), [XeF5][HF2]⋅CrOF4, and [XeF5][WOF5]⋅XeOF4

The reactions of the fluoride-ion donor, XeF₆, with the fluoride-ion acceptors, M′OF₄ (M′=Cr, Mo, W), yield [XeF₅]⁺ and [Xe₂F₁₁]⁺ salts of [M′OF₅]⁻ and [M₂O₂F₉]⁻ (M=Mo, W). Xenon hexafluoride and MOF₄ react in anhydrous hydrogen fluoride (aHF) to give equilibrium mixtures of [Xe₂F₁₁]⁺, [XeF₅]⁺, [(HF)_nF]⁻, [MOF₅]⁻, and [M₂O₂F₉]⁻ from which the title salts were crystallized. The [XeF₅][CrOF₅] and [Xe₂F₁₁][CrOF₅] salts could not be formed from mixtures of CrOF₄ and XeF₆ in aHF at low temperature (LT) owing to the low fluoride-ion affinity of CrOF₄, but yielded [XeF₅][HF₂]⋅CrOF₄ instead. In contrast, MoOF₄ and WOF₄ are sufficiently Lewis acidic to abstract F⁻ ion from [(HF)_nF]⁻ in aHF to give the [MOF₅]⁻ and [M₂O₂F₉]⁻ salts of [XeF₅]⁺ and [Xe₂F₁₁]⁺. To circumvent [(HF)_nF]⁻ formation, [Xe₂F₁₁][CrOF₅] was synthesized at LT in CF₂ClCF₂Cl solvent. The salts were characterized by LT Raman spectroscopy and LT single-crystal X-ray diffraction, which provided the first X-ray crystal structure of the [CrOF₅]⁻ anion and high-precision geometric parameters for [MOF₅]⁻ and [M₂O₂F₉]⁻. Hydrolysis of [Xe₂F₁₁][WOF₅] by water contaminant in HF solvent yielded [XeF₅][WOF₅]⋅XeOF₄. Quantum-chemical calculations were carried out for M′OF₄, [M′OF₅]⁻, [M′₂O₂F₉]⁻, {[Xe₂F₁₁][CrOF₅]}₂, [Xe₂F₁₁][MOF₅], and {[XeF₅][M₂O₂F₉]}₂ to obtain their gas-phase geometries and vibrational frequencies to aid in their vibrational mode assignments and to assess chemical bonding.     

Dearomatization of 3-Nitroindoles with Highly γ-Functionalized Allenoates in Formal (3+2) Cycloadditions

3-Nitroindoles are easily reacted with highly substituted γ-allenoates in the presence of a commercially available phosphine catalyst. For instance, allenoates derived from biomolecules such as amino and deoxycholic acids are combined for the first time with 3-nitroindole. The corresponding dearomatized (3+2) tricyclic cycloadducts are obtained as α-regioisomers exclusively. DFT computations shed light on this multi-step reaction mechanism and on the selectivities observed in the sequence.     

Photoinduced Mo−CN Bond Breakage in Octacyanomolybdate Leading to Spin Triplet Trapping

The photoinduced properties of the octacoordinated complex K₄Mo^IV(CN)₈⋅2 H₂O were studied by theoretical calculations, crystallography, and optical and magnetic measurements. The crystal structure recorded at 10 K after blue light irradiation reveals an heptacoordinated Mo(CN)₇ species originating from the light-induced cleavage of one Mo−CN bond, concomitant with the photoinduced formation of a paramagnetic signal. When this complex is heated to 70 K, it returns to its original diamagnetic ground state, demonstrating full reversibility. The photomagnetic properties show a partial conversion into a triplet state possessing significant magnetic anisotropy, which is in agreement with theoretical studies. Inspired by these results, we isolated the new compound [K(crypt-222)]₃[Mo^IV(CN)₇]⋅3 CH₃CN using a photochemical pathway, confirming that photodissociation leads to a stable heptacyanomolybdate(IV) species in solution.     

Fluorescent P-Hydroxyphosphole for Peptide Labeling through P-N Bond Formation

Synthesis of fluorescent P-hydroxybinaphtylphosphole-oxide or -sulfide was achieved by trapping a binaphtyl dianion with methyl dichlorophosphite or P-(N,N-diethylamino)dichlorophosphine, followed by oxidation or sulfuration of the P-center. After saponification or acid hydrolysis, the P-hydroxyphospholes were coupled to peptides using the coupling agent BOP, under the conditions required for the synthesis in solution or on a solid support. This new method was illustrated by the labeling of the JMV2959, a potent antagonist of the Growth Hormone Secretagogue Receptor type 1a (GHS−R1a). The labeled conjugates were used to characterize GHSR ligands by competition assays, based on Fluorescence Resonance Energy Transfer (FRET). Such P-hydroxyphosphole-oxide or -sulfide constitute a promising new class of compact fluorophores with large Stokes shift, for labeling biomolecules by grafting through the phosphorus atom.     

Metabolism of methylstenbolone studied with human liver microsomes and the uPA+/+‐SCID chimeric mouse model

Anti‐doping laboratories need to be aware of evolutions on the steroid market and elucidate steroid metabolism to identify markers of misuse. Owing to ethical considerations, in vivo and in vitro models are preferred to human excretion for nonpharmaceutical grade substances. In this study the chimeric mouse model and human liver microsomes (HLM) were used to elucidate the phase I metabolism of a new steroid product containing, according to the label, methylstenbolone. Analysis revealed the presence of both methylstenbolone and methasterone, a structurally closely related steroid. Via HPLC fraction collection, methylstenbolone was isolated and studied with both models. Using HLM, 10 mono‐hydroxylated derivatives (U1–U10) and a still unidentified derivative of methylstenbolone (U13) were detected. In chimeric mouse urine only di‐hydroxylated metabolites (U11–U12) were identified. Although closely related, neither methasterone nor its metabolites were detected after administration of isolated methylstenbolone. Administration of the steroid product resulted mainly in the detection of methasterone metabolites, which were similar to those already described in the literature. Methylstenbolone metabolites previously described were not detected. A GC‐MS/MS multiple reaction monitoring method was developed to detect methylstenbolone misuse. In one out of three samples, previously tested positive for methasterone, methylstenbolone and U13 were additionally detected, indicating the applicability of the method. Copyright © 2014 John Wiley & Sons, Ltd.